抗辐射性
癌症研究
基因敲除
核糖核酸
培美曲塞
生物
信使核糖核酸
细胞凋亡
程序性细胞死亡
化学
胶质母细胞瘤
免疫原性细胞死亡
细胞生物学
放射治疗
肿瘤微环境
溶瘤病毒
转录组
替莫唑胺
放射增敏剂
癌症
细胞生长
细胞
旁观者效应
下调和上调
细胞毒性T细胞
微泡
CD8型
细胞毒性
DNA损伤
细胞培养
RNA干扰
癌细胞
磷酸化
作者
Shushu Hu,Jinmei Cheng,Yuan Liu,Chen Chen,Rubin Qiu,Yantan Liu,Qinghua Zhang,Yuyin Xie,Binlong Wan,Peixin Tan,Dehuan Xie,Yuan Lei,Haizhen Luo,Wenqing Feng,Yushi Deng,Xin Hua,C-Y Ren,Shasha Du
标识
DOI:10.1186/s13046-026-03822-3
摘要
Abstract Background Radiotherapy is the standard treatment for glioblastoma (GBM), but its efficacy is severely compromised by radioresistance. While aberrant RNA modifications contribute to radioresistance, specific epitranscriptomic vulnerabilities remain underexplored. Methods We integrated quantitative proteomics, N 4 -acetylcytidine RNA immunoprecipitation sequencing (acRIP-seq), and CRISPR dependency screens to identify radioresistance drivers in GBM. Mechanisms were investigated through patient cohorts, the use of a catalytically inactive mutant (NAT10-G641E), RNA stability assays, and polysome profiling. Immunological and clinical translational effects were assessed via orthotopic mouse models and computational drug repurposing. Results We identified N-acetyltransferase 10 (NAT10), the RNA N 4 -acetylcytidine (ac4C) writer, as a core driver of GBM radioresistance and poor patient survival. Mechanistically, NAT10 deposits ac4C onto SLC7A11 mRNA, stabilizing its transcript and enhancing translational efficiency, t hereby fortifying cellular antioxidant defenses and enabling GBM cells to evade radiation-induced ferroptosis. Furthermore, targeting NAT10 induced immunogenic cell death (ICD) and orchestrated a “cold-to-hot” tumor microenvironment transformation, characterized by robust CD8 + T cell infiltration. To circumvent the toxicity of existing NAT10 inhibitors, we repurposed pemetrexed as a safe and effective alternative. Pemetrexed disrupted the NAT10/ac4C/SLC7A11 axis, yielding profound synergistic survival benefits when combined with radiotherapy. Conclusions NAT10 promotes GBM radioresistance via ac4C-mediated stabilization of SLC7A11 and evasion of ferroptosis. Repurposing pemetrexed to inhibit NAT10 presents a promising strategy to sensitize refractory GBM to radiotherapy by simultaneously triggering ferroptosis and enhancing anti-tumor immunity.
科研通智能强力驱动
Strongly Powered by AbleSci AI